Buscar resultados de ensayos clínicos
Lymphoblastic Lymphoma - 26 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma Condición: Lymphoma, Lymphoblastic Fecha: 2015-03-18 Intervenciones:
|
Recruiting |
Nombre del estudio: BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma Condición:
|
Terminated |
Nombre del estudio: A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar) Condición:
Fecha: 2014-09-22 Intervenciones: Drug: pegcrisantaspase |
Active, not recruiting |
Nombre del estudio: Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Condición:
|
Recruiting |
Nombre del estudio: Hyper-CVAD Plus Nelarabine in Untreated T-ALL/Lymphoblastic Lymphoma Condición:
|
Recruiting |
Nombre del estudio: LBL-2016 for Children or Adolescents in China Condición: Lymphoblastic Lymphoma Fecha: 2016-07-24 Intervenciones:
|
Completed |
Nombre del estudio: Treatment of Relapsed T-Cell Acute Lymphoblastic Leukemia or T-Lymphoblastic Lymphoma With MabCampath Condición:
|
Not yet recruiting |
Nombre del estudio: Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR) Condición:
|
Recruiting |
Nombre del estudio: Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Condición:
|
Not yet recruiting |
Nombre del estudio: Study of Clofarabine, Etoposide, Cyclophosphamide [CEC], Liposomal Vincristine (VCR), Dexamethasone and Bortezomib in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL) Condición:
Intervenciones: |